Vasculitis Trial, Recruiting (NCT05865054)

Vasculitis Trial, Recruiting NCT05865054 Sponsor: University of Pennsylvania Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT05865054 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 50 years old or older
This is the first time you are being assessed for a condition called Giant Cell Arteritis (GCA)
You have developed new or worsening symptoms affecting your head or face (such as headaches or jaw pain) within the last 4 weeks that may be related to GCA
A blood test has shown that a marker of inflammation in your body (called CRP) is above a certain level
Your doctor is planning to do a biopsy (small tissue sample) or an ultrasound of an artery near your temple to help diagnose your condition

Who may not be able to join:

You have an implanted medical device or pacemaker, or have any metal fragments inside your body or eyes that would make having an MRI scan unsafe
You have a known allergy to a dye called gadolinium, which is used during MRI scans
You are currently pregnant or breastfeeding
Your symptoms do not include any head or face-related signs of GCA — for example, if only the larger blood vessels in your body appear to be affected, with no symptoms in the head area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rennie Rhee, MD, University of Pennsylvania

Phone: 917-548-2067

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05865054

Sponsor: University of Pennsylvania

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: 917-548-2067

More information: https://clinicaltrials.gov/study/NCT05865054

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 50 years old or older
This is the first time you are being assessed for a condition called Giant Cell Arteritis (GCA)
You have developed new or worsening symptoms affecting your head or face (such as headaches or jaw pain) within the last 4 weeks that may be related to GCA
A blood test has shown that a marker of inflammation in your body (called CRP) is above a certain level
Your doctor is planning to do a biopsy (small tissue sample) or an ultrasound of an artery near your temple to help diagnose your condition

Who may not be able to join:

You have an implanted medical device or pacemaker, or have any metal fragments inside your body or eyes that would make having an MRI scan unsafe
You have a known allergy to a dye called gadolinium, which is used during MRI scans
You are currently pregnant or breastfeeding
Your symptoms do not include any head or face-related signs of GCA — for example, if only the larger blood vessels in your body appear to be affected, with no symptoms in the head area

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Pennsylvania

Registry

ClinicalTrials.gov

Start date

29 July 2020

Est. completion

1 July 2030

Where this trial is recruiting

🇨🇦 Canada 🇩🇪 Germany 🇺🇸 United States

Primary endpoints

Vessel Wall Enhancement Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov